Rescuing the function of mutant p53.
One protein--p53--plays nemesis to most cancers by condemning damaged cells to death or quarantining them for repair. But the activity of p53 relies on its intact native conformation, which can be lost following mutation of a single nucleotide. With thousands of such mutations identified in patients, how can a future cancer drug buttress this fragile protein structure and restore the cell's natural defence?
Bullock
A N
AN
Department of Biochemistry, University of Washington, Seattle, USA.
Fersht
A R
AR
D000818:Animals; D001549:Benzamides; D004247:DNA / Q000378:metabolism; D006801:Humans; D000068877:Imatinib Mesylate; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use; D017510:Protein Folding; D011743:Pyrimidines / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000502:physiology*
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D016159:Tumor Suppressor Protein p53; D000068877:Imatinib Mesylate; D004247:DNA